Company intelligence / Profile preview

Neursantys

Chicago, Illinois, United Statesneursantys.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Neursantys has launched NEURVESTA, a non-invasive wearable bioelectronic device that uses low-level electrical vestibular stimulation to diagnose and treat age-related balance and mobility disruptions. Early results indicate the technology can trigger neuroplastic recovery of degraded balance, with ongoing R&D targeting additional neuromotor conditions such as multiple sclerosis, head trauma, and spaceflight-induced impairment.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyBioelectronic therapy (non-invasive neurostimulation)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

NEURVESTA

Pre-clinical

Indications: Age-related balance decline, Multiple sclerosis, Head impact injuries

Partnerships

LeadingAge California (Premier Business Partner)Various R&D/manufacturing/clinical/regulatory partners in US, Canada, UK, Europe

Beyond the preview

Go deeper on Neursantys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neursantys.

Explore the full profile